Kingstone Capital Partners Texas, LLC Merck & Co., Inc. Transaction History
Kingstone Capital Partners Texas, LLC
- $624 Billion
- Q2 2025
A detailed history of Kingstone Capital Partners Texas, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Kingstone Capital Partners Texas, LLC holds 3,262,591 shares of MRK stock, worth $273 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
3,262,591Holding current value
$273 Million% of portfolio
0.06%Shares
1 transactions
Others Institutions Holding MRK
# of Institutions
3,892Shares Held
1.93BCall Options Held
26.2MPut Options Held
23.5M-
Vanguard Group Inc Valley Forge, PA253MShares$21.1 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY207MShares$17.3 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$10.1 Billion0.46% of portfolio
-
Wellington Management Group LLP Boston, MA81.7MShares$6.83 Billion1.46% of portfolio
-
Geode Capital Management, LLC Boston, MA59.7MShares$4.99 Billion0.43% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $212B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...